Table 1. Clinical characteristics of the study patients who had their treatment modification based on FDG PET/CT findings (n = 13).
No. | Age/Sex | Clinical history | Type of sepsis | Blood culture results | FDG PET/CT findings | Treatment modality | Clinical outcome | Days in hospital |
1 | 84/M | LC | Nosocomial | Citrobacter diversus, Enterococcus faecalis, Escherichia coli | Biliary tract infection | PTCD | Cured | 83 |
2 | 40/M | LC | Nosocomial | Staphylococcus aureus | Spine infectious spondylitis (L4-5) | Surgery | Cured | 93 |
3 | 78/M | - | Community-acquired | S. aureus | Spine infectious spondylitis (T9-L4), psoas muscle abscess, pleural empyema | Surgery | Expired | 60 |
4 | 52/F | - | Nosocomial | Enterococcus faecium | Intramuscular abscess of the adductor muscle of the thigh | CT-guided drainage | Cured | 157 |
5 | 86/M | DM,HTN,COPD | Nosocomial | Enterobacter cloacae | Spine infectious spondylitis (T8-9) | Surgery | Expired | 79 |
6 | 64/M | DM,HTN,CAD | Community-acquired | S. aureus | Spine infectious spondylitis (C5-6) | Surgery | Cured | 50 |
7 | 60/F | - | Community-acquired | S. aureus | Spine infectious spondylitis (L5-S1) | Surgery | Cured | 50 |
8 | 60/M | DM, HTN, LC | Community-acquired | S. aureus | Spine infectious spondylitis (T8-9) | Surgery | Expired | 136 |
9 | 48/M | - | Community-acquired | S. aureus | Septic arthritis of the hip joint, iliac fossa abscess | Surgery | Cured | 32 |
10 | 57/F | - | Community-acquired | S. aureus | Psoas muscle abscess | CT-guided drainage | Cured | 29 |
11 | 60/M | DM,CKD | Community-acquired | S. aureus | Spine infectious spondylitis (C6-7, L5-S1) | Surgery | Cured | 84 |
12 | 59/M | HTN,ESRD | Community-acquired | S. aureus | Psoas muscle abscess | CT-guided drainage | Cured | 54 |
13 | 64/F | CAD,ESRD | Community-acquired | S. aureus | Spine infectious spondylitis (L3-4) | Surgery | Cured | 64 |
M, male; F, female; LC, liver cirrhosis; DM, diabetes mellitus; HTN, hypertension; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; ESRD, end-stage renal disease; PTCD, percutaneous transhepatic cholangiography and biliary drainage.